3.0.0
3622
2024-10-19T08:05:18Z
2024-10-19T08:05:18Z
House
H
HR
2023-05-24
118
[Congressional Record Volume 169, Number 88 (Wednesday, May 24, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Ms. SCHAKOWSKY:H.R. 3622.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 3: The Congress shall havePower . . . To regulate Commerce with foreign Nations, andamong the several States, and with the Indian Tribes.The single subject of this legislation is:To amend title VI of the Federal Food, Drug, and CosmeticAct to ensure the supply chain transparency needed forcompanies to make safe cosmetics, and for other purposes.[Page H2597]
- hsif00
Energy and Commerce Committee
House
Standing
  - hsif14
Health Subcommittee
    - Referred to
2023-05-26T14:52:44Z
  - Referred to
2023-05-24T14:02:45Z
- 2023-05-26
  - hsif14
Health Subcommittee
1
House committee actions
Referred to the Subcommittee on Health.
Committee
- 2023-05-24
Referred to the House Committee on Energy and Commerce.
IntroReferral
H11100
2
House floor actions
  - hsif00
Energy and Commerce Committee
- 2023-05-24
Introduced in House
IntroReferral
Intro-H
9
Library of Congress
- 2023-05-24
Introduced in House
IntroReferral
1000
9
Library of Congress
- S001145
Rep. Schakowsky, Janice D. [D-IL-9]
JANICE
SCHAKOWSKY
D
IL
D.
9
N
- N000147
Del. Norton, Eleanor Holmes [D-DC-At Large]
ELEANOR
NORTON
D
DC
HOLMES
0
2023-05-24
True
- T000481
Rep. Tlaib, Rashida [D-MI-12]
Rashida
Tlaib
D
MI
12
2023-05-24
True
- V000081
Rep. Velazquez, Nydia M. [D-NY-7]
NYDIA
VELAZQUEZ
D
NY
M.
7
2023-05-24
True
- G000551
Rep. Grijalva, Raúl M. [D-AZ-7]
Raúl
Grijalva
D
AZ
M.
7
2023-05-24
True
- J000288
Rep. Johnson, Henry C. "Hank," Jr. [D-GA-4]
Henry
Johnson
D
GA
C. "Hank"
4
2023-05-24
True
- M001188
Rep. Meng, Grace [D-NY-6]
Grace
Meng
D
NY
6
2023-05-24
True
- C001127
Rep. Cherfilus-McCormick, Sheila [D-FL-20]
Sheila
Cherfilus-McCormick
D
FL
20
2023-06-06
False
- L000397
Rep. Lofgren, Zoe [D-CA-18]
ZOE
LOFGREN
D
CA
18
2023-06-16
False
- W000788
Rep. Williams, Nikema [D-GA-5]
Nikema
Williams
D
GA
5
2024-05-06
False
- B001313
Rep. Brown, Shontel M. [D-OH-11]
Shontel
Brown
D
OH
M.
11
2024-05-14
False
- J000032
Rep. Jackson Lee, Sheila [D-TX-18]
Sheila
Jackson Lee
D
TX
18
2024-05-21
False
- S001218
Rep. Stansbury, Melanie A. [D-NM-1]
Melanie
Stansbury
D
NM
A.
1
2024-06-03
False
- D000624
Rep. Dingell, Debbie [D-MI-6]
Debbie
Dingell
D
MI
6
2024-09-17
False
- M001163
Rep. Matsui, Doris O. [D-CA-7]
Doris
Matsui
D
CA
O.
7
2024-10-18
False
Health
- Administrative law and regulatory procedures
2023-10-30T19:01:05Z
- Advisory bodies
2023-10-30T19:01:05Z
- Business records
2023-10-30T19:01:05Z
- Civil actions and liability
2023-10-30T19:01:05Z
- Cosmetics and personal care
2023-10-30T19:01:05Z
- Drug safety, medical device, and laboratory regulation
2023-10-30T19:01:05Z
- Food and Drug Administration (FDA)
2023-10-30T19:01:05Z
- Government information and archives
2023-10-30T19:01:05Z
- Hazardous wastes and toxic substances
2023-10-30T19:01:05Z
- Retail and wholesale trades
2023-10-30T19:01:05Z
Health
2023-06-16T11:46:12Z
00
2023-05-24
Introduced in House
2023-10-17T15:42:15Z
Cosmetic Supply Chain Transparency Act of 2023
This bill requires the Food and Drug Administration (FDA) to maintain a list of certain nonfunctional constituents in cosmetics that are harmful to human health or the environment, authorizes the FDA to request from a brand owner (i.e., the entity bringing a cosmetic to market) certain information about a cosmetic's ingredients, and addresses related issues.
For each listed nonfunctional constituent, the list must identify the ingredient or cosmetic (or category of ingredient or cosmetic) in which the constituent is known or reasonably expected to be present. The FDA must also (1) establish procedures for petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.
Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.
Brand owners must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.
The bill also imposes civil penalties for brand owners and suppliers that violate this bill's provisions.

Cosmetic Supply Chain Transparency Act of 2023
- Display Title
45

Cosmetic Supply Chain Transparency Act of 2023
2024-06-11T16:02:21Z
- Short Title(s) as Introduced
101

Cosmetic Supply Chain Transparency Act of 2023
2024-05-24T13:39:29Z
Introduced in House
IH
- Official Title as Introduced
6

To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
2024-03-18T20:52:59Z
Introduced in House
IH
- Introduced in House
2023-05-24T04:00:00Z
  - https://www.govinfo.gov/content/pkg/BILLS-118hr3622ih/xml/BILLS-118hr3622ih.xml
2023-05-26
Referred to the Subcommittee on Health.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.